[Not Available].
作者信息
Morgan Steven G, Herder Matthew
机构信息
School of Population and Public Health (Morgan), University of British Columbia, Vancouver, C.-B.; Health Law Institute (Herder), Schulich School of Law, et Département de pharmacologie (Herder), Faculté de médecine, Dalhousie University, Halifax, N.-É.
出版信息
CMAJ. 2024 Oct 6;196(33):E1157-E1159. doi: 10.1503/cmaj.240935-f.
Abstract
摘要
相似文献
1
[Not Available].
CMAJ. 2024 Oct 6;196(33):E1157-E1159. doi: 10.1503/cmaj.240935-f.
本文引用的文献
1
Resignations at Canada's drug pricing panel raise independence questions.
CMAJ. 2023 Mar 14;195(10):E378-E379. doi: 10.1503/cmaj.1096044.
2
On Measuring the Inequity of Financing Health Care in the United States and the Redistribution of Income Through Health Care Financing in Canada.
Am J Public Health. 2020 Nov;110(11):1603-1604. doi: 10.2105/AJPH.2020.305891.
3
Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.
J Pharm Policy Pract. 2018 Nov 7;11:28. doi: 10.1186/s40545-018-0154-x. eCollection 2018.
4
Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Health Econ. 2008 Dec;17(12):1379-92. doi: 10.1002/hec.1337.
Zotero 插件